2012
DOI: 10.1093/jb/mvs139
|View full text |Cite
|
Sign up to set email alerts
|

Functional characterization of the recombinant human tumour suppressor 101F6 protein, a cytochrome b561 homologue

Abstract: Candidate human tumour suppressor gene product, 101F6 protein, is a highly hydrophobic transmembrane protein and a member of cytochrome b(561) family. Purified 101F6 protein expressed in Pichia pastoris cells showed visible absorption spectra similar but distinct from those of cytochrome b(561). Haem content analysis indicated presence of two haems B per molecule. Midpoint potentials of the purified protein were found as +109 and +26 mV for two haems, slightly lower than those for bovine chromaffin granule or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 10 publications
(29 citation statements)
references
References 45 publications
1
21
0
Order By: Relevance
“…1). It is reported the Cys106 of human DJ-1 which is equivalent to Cys100 in PH1704 is the most sensitive residue under the oxidative environment [33], [34]. Cys185 of Hsp31 was identified as nucleophilic site by inhibition and mutational test [5][7].…”
Section: Resultsmentioning
confidence: 99%
“…1). It is reported the Cys106 of human DJ-1 which is equivalent to Cys100 in PH1704 is the most sensitive residue under the oxidative environment [33], [34]. Cys185 of Hsp31 was identified as nucleophilic site by inhibition and mutational test [5][7].…”
Section: Resultsmentioning
confidence: 99%
“…Expression and purification of 101F6 protein were conducted by employing alcohol-assimilating yeast Pichia pastoris cells and pPICZB-101F6-His8 plasmid (Recuenco et al 2013a, Recuenco et al 2013b. In brief, human 101F6 gene was incorporated into the Pichia genome and successful transformants were selected by zeocin-resistance screening.…”
Section: Methodsmentioning
confidence: 99%
“…The linearized plasmid pPICZB-Cecytb-2-H6 with PmeI was inserted into the P. pastoris GS115 genome using EasyComp transformation protocol (Invitrogen Corp., Tokyo, Japan). Successfully transformed cells were selected on Yeast Extract Peptone Dextrose Sorbitol Medium (YPDS) agar plates containing 100-400 µg/mL Zeocin (Invitrogen Corp.) The culture for the Cecytb-2 expression was done as previously reported in [27], (Miura et al, unpublished results). The purification of the expressed Cecytb-2 was performed with Ni-Sepharose affinity column as described in [27,28] with some modification (for detailed procedures, see Supplementary file) (Miura et al, unpublished results).…”
Section: Expression and Purification Of Cecytb-2mentioning
confidence: 99%
“…Successfully transformed cells were selected on Yeast Extract Peptone Dextrose Sorbitol Medium (YPDS) agar plates containing 100-400 µg/mL Zeocin (Invitrogen Corp.) The culture for the Cecytb-2 expression was done as previously reported in [27], (Miura et al, unpublished results). The purification of the expressed Cecytb-2 was performed with Ni-Sepharose affinity column as described in [27,28] with some modification (for detailed procedures, see Supplementary file) (Miura et al, unpublished results). UV-visible absorption spectra of the purified Ceytb-2 protein were recorded in a region from 700 to 200 nm using a Shimadzu UV-2400PC spectrophotometer (Shimadzu Corp., Kyoto, Japan).…”
Section: Expression and Purification Of Cecytb-2mentioning
confidence: 99%